# Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

> **NCT00001452** · — · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 1387 (actual)

## Conditions studied

- Cushing's Syndrome
- Pituitary Adenoma
- Carney Complex
- Primary Pigmented Nodular Adrenocortical Disease
- Peutz-Jeghers Syndrome

## Interventions

- **DRUG:** oCRH

## Key facts

- **NCT ID:** NCT00001452
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12-14
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1387 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001452, "Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*